Evolution of the Average Target: Dolby Laboratories, Inc.

Evolution of the Average Target - Dolby Laboratories, Inc.

Evolution of the Target Price: Dolby Laboratories, Inc.

Evolution of the Target Price - Dolby Laboratories, Inc.

Changes in Analyst Recommendations: Dolby Laboratories, Inc.

0a7c5c658439f36de7117ff.tu5lYRDS5XNAfjbFkX1c8VP1_GWOBaXJlaCRF8HhifA.3J8OInaxthIyB1SVphsFiAmPliT4UOSF0fjlRInV3MnGgh8CdIKRFRErZw~5df284eb4dc5c27b3b8b7f9e02c7e4be
Nov. 19 Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating MT
25-09-05 Baird Initiates Dolby Laboratories at Neutral With $74 Price Target MT
25-08-15 Dolby Laboratories' Immersive Media Innovation, Strategic Partnerships to Drive Long-Term Growth, Tigress Financial Partners Says MT
25-08-15 Tigress Adjusts Price Target on Dolby Laboratories to $114 From $112, Maintains Buy Rating MT
24-06-03 Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target is $100 MT
23-08-04 Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating MT
23-02-03 Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating MT
22-11-18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes MT
22-11-18 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform MT
22-11-07 Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating MT
22-10-14 Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept MT
22-05-24 Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target MT
22-05-12 Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating MT
21-08-02 Dolby Laboratories : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target MT
21-01-29 Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating MT
21-01-04 Dolby Laboratories : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform MT
20-11-13 Dolby Laboratories : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating MT
20-11-13 Dolby Laboratories : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating MT
20-11-13 Dolby Laboratories : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+28.1%
+13.96%
+6.18%
+63.14%
+1.02%
-7.28%
+13.13%
+4.66%
-2.66%
+5.77%
Average +12.60%
Weighted average by Cap. +14.51%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
62.91USD
Average target price
79.00USD
Spread / Average Target
+25.58%
High Price Target
90.00USD
Spread / Highest target
+43.06%
Low Price Target
62.00USD
Spread / Lowest Target
-1.45%

Analyst Consensus Detail

Analyst consensus - Dolby Laboratories, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Dolby Laboratories, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Dolby Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Consensus Dolby Laboratories, Inc.